-
PROVIDERS
REGISTER NOW
Upcoming Webinar:
MRD data insights across the cancer care continuum -
LIFE SCIENCES
Read now
Accelerating a phase 1 oncology trial: The TIME Network's impact on patient enrollment
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
PROVIDERS /// DATA COLLABORATIONS
At Tempus, our mission is to improve the options available to patients living with disease. We believe that by connecting researchers with real-world data—a vast library of de-identified data capturing the real-world experience of patients—we can make sure every patient benefits from the experiences of those who came before. We have developed the industry’s most comprehensive multi-modal, de-identified dataset, used to help researchers identify new insights, design better clinical trials, and develop new therapies.
what we offer
We welcome everyone to join us in this journey
If your organization has a real-world data-set that can be used to accelerate healthcare research and discovery, we will work with you to make it available to academic and life sciences researchers.
Learn more about how to join- Data structuring and de-identification services
- Data harmonization and mapping to common data model
- Secure data transfer and hosting solutions
- Access to Lens, Tempus’ proprietary analytics platform, for use by your researchers
- Access to Tempus One, our conversational AI assistant, to derive insights from the data library
- A fair market value royalty (typically 15%, depending on data type and the availability of longitudinal updates) if Tempus licenses de-identified data contributed by your organization, to support your own internal research and innovation initiatives
Participation requirements
- You must be a US-based organization that has the legal right to contribute your dataset for de-identified use in the Tempus platform
- Your data must meet Tempus’ minimum data quality requirements, which generally require contribution of clinical data (demographic and clinical data, including unstructured information such as progress notes) and available molecular data (DNA and RNA results, including raw molecular files)
- A commitment to supplement data longitudinally at regular intervals, if applicable, which can be accomplished through our secure data transfer and hosting solutions
The data collaboration program described above does not require, and is not intended to encourage, that your organization orders or purchases any other products or services from Tempus, including clinical testing services.